Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 8 spellings of its name, each linked to the record. See the Novartis group view.
As of Nov 14, 2026, FDA's public records list Novartis Pharmaceuticals Corporation and its 8 subsidiaries with 205 drug applications, 67 510(k) clearances, 37 drug recalls, 5 OPDP letters and 1 complete response letter. The most recent is an OPDP letter dated Sep 23, 2025: Untitled letter: FABHALTA.
Group recordsLabelled by a language model (which subsidiaries belong to the group) from the firm's FDA names. It is not an FDA field.: 315, 9 entities
Drug applications: 205
510(k) clearances: 67
Drug recalls: 37
OPDP letters: 5
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Novartis Pharmaceuticals Corporation and its 8 subsidiaries
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
62017Records6
020182018Records0vs 2017−6
72019Records7vs 2018+7
320202020Records3vs 2019−4
22021Records2vs 2020−1
920222022Records9vs 2021+7
72023Records7vs 2022−2
320242024Records3vs 2023−4
22025Records2vs 2024−1
120262026 to dateRecords1
Latest Records
Newest first across sources; each opens the record
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
